| 英文名稱 | 20(R)Ginsenoside Rg3 |
|---|---|
| 中文名稱 | R型人參皂苷Rg3/20(R型)人參皂苷Rg3/20(R)人參皂苷Rg3/R-人參皂苷Rg3/(R)人參皂苷Rg3/20(R)-人參皂苷Rg3/人參皂苷R型Rg3/20(R)-人參皂苷Rg3（R型） |
| CAS號 | 38243-03-7 |
| 分子式 | C42H72O13 |
| 分子量 | 785.02 |
| 外觀 | 白色粉末 |
| 熔點(diǎn) | 315-318 °C |
| 沸點(diǎn) | 885.0±65.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000036
中文名稱：R型人參皂苷Rg3
中文別名：20(R型)人參皂苷Rg3；20(R)人參皂苷Rg3；R-人參皂苷Rg3；(R)人參皂苷Rg3；20(R)-人參皂苷Rg3；人參皂苷R型Rg3；20(R)-人參皂苷Rg3（R型）
英文名稱：20(R)Ginsenoside Rg3
英文別名：(3β,12β,20R)-12,20-Dihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside;(3β,12β,20R)-12,20-Dihydroxydammar-24-en-3-yl O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside;20(R)-Ginsenoside Rg3;20(R)-Propanaxadiol;20R-Ginsenoside Rg3;Ginsenoside R-Rg3;Ginsenoside rg3(R);R-Ginsenoside Rg3;
分子式：C42H72O13
分子量：785.01
CAS號：38243-03-7
純度：HPLC≥98%
熔點(diǎn)：315-318 °C
沸點(diǎn)：885.0±65.0 °C | Condition: Press: 760 Torr
密度：1.30±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：12.85±0.70 | Condition: Most Acidic Temp: 25 °C
儲存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Steamed Panax notoginseng attenuates renal anemia in an adenine-induced mouse model of chronic kidney disease | ||
| 來源：SCI：JOURNAL OF ETHNOPHARMACOLOGY | 作者：Min Gao | 備注：影響因子：4.36 |
| 引用描述 | ||
The reference standards of notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rc, 20(S)–Rh1, 20(R)-Rh1, Rd, Rg6, F4, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5, all with a purity ≥98%, were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). EPO was purchased from Chengdu Di'ao Jiuhong Pharmaceutical Factory (Chengdu, Sichuan, China). FEJ was purchased from Shandong Dong'e E'jiao Co., Ltd. | ||
| Steamed Panax notoginseng Attenuates Anemia in Mice With Blood Deficiency Syndrome via Regulating Hematopoietic Factors and JAK-STAT Pathway | ||
| 來源：SCI：Frontiers in Pharmacology | 作者：Yin Xiong, | 備注：影響因子：4.225 |
| 引用描述 | ||
Qualitative and quantitative analyses of SPN were performed as previous report (Xiong et al., 2017a). In brief, notoginsenoside R1 and ginsenosides Rg1, Re, 20(R)-Rh1, Rb1, Rd, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Sichuan, China) with purity ≧ 98% were used as standard compounds. The analysis was performed on an Agilent 1260HPLC system (Agilent Technologies) equipped with a G1311B Pump, a G4212B DAD detector, and a G1329B autosampler. | ||
| Optimisation of Ethanol-Reflux Extraction of Saponins from Steamed Panax notoginseng by Response Surface Methodology and Evaluation of Hematopoiesis Effect | ||
| 來源：SCI：MOLECULES | 作者：Yupiao Hu | 備注：影響因子：3.098 |
| 引用描述 | ||
Acetonitrile of chromatographic grade and ferrous chloride and hydrogen peroxide of analytical grade were purchased from Merck Chemical Co. (Darmstadt, Germany). Notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rd, Rh1, Rk3, Rh4, 20(S)-Rg3, and 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Chengdu, China) with a purity ≥ 98% were used as the standard compounds. | ||
